Safety

Company Announcement

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Shadow Holdings, LLC Issues Voluntary Nationwide Recall of X-Jow and Acne Shave products due to Possible Bacterial Contamination

For Immediate Release

May 25, 2018

Contact

Consumers and Media

661-673-8519

Announcement

Shadow Holdings is voluntarily recalling all lots, within expiry, of Herb-X Solutions X-Jow Pain Gel, and United Exchange Acne Shave Moisturizer, Acne Shave Shave Cream with Acne Shield, and Acne Shave Shave Kit to the retail level. The products may be contaminated with bacteria.

Topical administration of the products could result in potentially serious bacterial infections in immunocompromised individuals. To date, Shadow Holdings has not received any reports of adverse events related to this recall.

Herb-X Solutions X-Jow Pain Gel is used as an external analgesic, which is packaged in 4 oz. and 8 oz. bottles. The United Exchange Acne Shave Moisturizer and Acne Shave Shave Cream with Acne Shield are used as topical acne medications, and are packaged in 3.3 oz. and 5.1 oz. bottles respectively. The United Exchange Acne Shave Shave Kit contains potentially affected units of both the Acne Shave Moisturizer and the Acne Shave Shave Cream with Acne Shield. 

DistributorProduct Description
Herb-X SolutionsX-Jow Pain Gel, 4oz.
X-Jow Pain Gel, 8oz.
United ExchangeAcne Shave Moisturizer, 3.3 oz.
Acne Shave Shave Cream with Acne Shield, 5.1 oz.
Acne Shave Shave Kit

The products were distributed nationwide to retail and wholesale outlets.

Shadow Holdings is notifying its distributors and customers by written notification.  Consumers, distributors, and retailers that have the products, which are being recalled, should stop using and discard the products.

Consumers with questions regarding this recall can contact Shadow Holdings by calling 661-673-8519 Monday – Friday 8am – 5pm., Pacific Daylight Time (PDT).  Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
 

###

Page Last Updated: 05/25/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English